Inventor
GRANT STEVEN
US26 patents
⚠️ This page may combine multiple inventors who share the name “GRANT STEVEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
8 patentsUS9228018B2Jan 5, 2016
Antibody polypeptides that antagonize CD40L
BRISTOL MYERS SQUIBB CO11 citations91
US8895010B2Nov 25, 2014
Antibody polypeptides that antagonize CD40L
BRISTOL MYERS SQUIBB CO24 citations91
US9765150B2Sep 19, 2017
Antibody polypeptides that antagonize CD40L
BRISTOL MYERS SQUIBB CO5 citations82
US8981072B2Mar 17, 2015
Nucleic acids encoding antibody polypeptides that antagonize CD40L
BRISTOL MYERS SQUIBB CO8 citations82
US10196451B2Feb 5, 2019
Methods of treating immune diseases by administering antibody polypeptides that specifically bind CD40L
BRISTOL MYERS SQUIBB CO1 citations71
US10544228B2Jan 28, 2020
Nucleic acids encoding antibody polypeptides that antagonize CD40
BRISTOL MYERS SQUIBB CO1 citations69
US11180567B2Nov 23, 2021
Antibody polypeptides that antagonize CD40L
BRISTOL MYERS SQUIBB CO0 citations61
US11136406B2Oct 5, 2021
Methods of treating immune diseases by administering antibody polypeptides that antagonize CD40
BRISTOL MYERS SQUIBB CO0 citations59
DOMANTIS LTD
3 patentsUS7563443B2Jul 21, 2009
Monovalent anti-CD40L antibody polypeptides and compositions thereof
DOMANTIS LTD42 citations95
US7927596B2Apr 19, 2011
Methods of antagonizing binding of CD40 to CD40L with CD40L-specific monovalent polypeptides
DOMANTIS LTD5 citations72
US7829096B2Nov 9, 2010
CD40L-specific monovalent polypeptides
DOMANTIS LTD4 citations72
BIOSCEPTRE AUST PTY LTD
3 patentsUS10053508B2Aug 21, 2018
Anti P2X7 receptor antibodies and fragments thereof
BIOSCEPTRE AUST PTY LTD5 citations83
US10988532B2Apr 27, 2021
Anti P2X7 receptor antibodies and fragments thereof
BIOSCEPTRE AUST PTY LTD2 citations72
US12129295B2Oct 29, 2024
Anti P2X7 receptor antibodies and fragments thereof
BIOSCEPTRE AUST PTY LTD0 citations61
GLAXOSMITHKLINE IP DEV LTD
3 patentsUS11613571B2Mar 28, 2023
Biopharmaceutical compositions comprising antibody variants
GLAXOSMITHKLINE IP DEV LTD0 citations56
US11976113B2May 7, 2024
Biopharmaceutical compositions comprising nucleic acids encoding IL-5 binding proteins
GLAXOSMITHKLINE IP DEV LTD0 citations55
US10787509B2Sep 29, 2020
Biopharmaceutical compositions and related methods
GLAXOSMITHKLINE IP DEV LTD1 citations55